Effect of supplementation in treatment of polycystic ovary syndrome
Not Applicable
- Conditions
- Polycystic ovary syndrome.Sclerocystic ovary syndrome Stein-Leventhal syndrome
- Registration Number
- IRCT201311205623N12
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 75
Inclusion Criteria
Inclusion Criteria: Women aged 18-35 years; diagnosed with PCOS.
Exclusion Criteria
Individuals with neoplastic; cardiovascular disorders; malabsorptive disorders; current or previous (within the last 6 months) use of hormonal; antidiabetic medications; anti-obesity medications.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method itric oxide. Timepoint: Baseline and End-of-trial. Method of measurement: Spectrophotometry.;Malondialdehyde. Timepoint: Baseline and End-of-trial. Method of measurement: Spectrophotometry.;Total Antioxidant Capacity. Timepoint: Baseline and End-of-trial. Method of measurement: Spectrophotometry.;Total glutathione. Timepoint: Baseline and End-of-trial. Method of measurement: Spectrophotometry.;Catalase. Timepoint: Baseline and End-of-trial. Method of measurement: Spectrophotometry.
- Secondary Outcome Measures
Name Time Method